The Use of Primidone in the Treatment of Refractory Bipolar Disorder

References

• Takesazi H, Hanoaka M: The use of carbamazepine (Te-gretol) in the control of manic-depressive psychosis and other manic depressive states. Clin Psychiatry 1971; 13:173–182
   Google Scholar
• Ballenger JC, Post RM: Therapeutic effects of carbamazepine in affective illness: A preliminary report. Commun Psycho-pharmacol 1978; 2:159–175
   PubMedGoogle Scholar
• Grossi E, Sacchetti E, Vita A, Conte G, Faravelli C, Hautman G, Zerbi D, Mesina AM, Drago F, Motta A: Carbamazepine vs. chlorpromazine in mania: A double-blind trial. In: Emrich HM, Okuma T, Muller AA, eds. Anticonvulsants in Affective Disorders. Amsterdam: Excerpta Medica; 1984:177–187
   Google Scholar
• Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA: Carbamazepine versus haloperidol for the treat-ment of acute manic episodes. Abstract presented at the 149th annual meeting of the American Psychiatric Association, New York, May 1996
   Google Scholar
• Lerer B, Moore N, Meyendoff E, Cho SR, Gershon S: Carba-mazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987; 48:89–93
   PubMed Web of Science ®Google Scholar
• Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe M: Comparison of the antimanic effi-cacy of carbamazepine. Psychopharmacology (Berl) 1979; 66:211–217
   PubMed Web of Science ®Google Scholar
• Post RM, Ballanger JC, Uhde TW, Bunney WE: Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms. In: Post RM, Ballanger JC, eds. Neu-robiology of Mood Disorders. Baltimore: Williams & Wil-kins; 1984:77–816
   Google Scholar
• Small JG, Klapper MH, Milstein V, Kellams JJ, Miller JD, Marhenke JD, Small IF: Carbamazepine compared with lith-ium in the treatment of mania. Arch Gen Psychiatry 1991; 48:915–921
   PubMed Web of Science ®Google Scholar
• Lambert PA, Cavaz G, Borselli S, Carbel S: Action neuropsy-chotrope d'un nouvel anti-epilptique: le Depamide. Ann Med Psychol (Paris) 1966; 1:707–710
   Google Scholar
• Emrich HM, Dose M, von Zerssen D: The use of sodium valproate, carbamazepine, and oxcarbamazepine in patients with affective disorders. J Affect Disord 1985; 8:243–250
   PubMed Web of Science ®Google Scholar
• Brennan MJW, Sandyk R, Borsook D: Use of sodium val-proate in the management of affective disorders: basic and clinical aspects. In: Emrich HM, Okuna T, Muller AA, eds. Anticonvulsans in Affective Disorders. Amsterdam: Excerpta Medica; 1984:56–65
   Google Scholar
• Post RM, Berettini W, Uhde TW, Kellner C: Selective re-sponse to the anticonvulsant carbamazepine in manic de-pressive illness: A case study. J Clin Psychopharmacol 1984; 4:178–185
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI: Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991; 48:62–68
   Google Scholar
• Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC: A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108–111
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994; 271:918–924
   Google Scholar
• McElroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM: A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996; 57:142–146
   PubMed Web of Science ®Google Scholar
• Schaffer CB, Schaffer LC: Gabapentin in the treatment of bipolar disorder [letter]. Am 3 Psychiatry 1997; 154:291–292
   PubMedGoogle Scholar
• Stanton SP, Keck PE Jr, McElroy SL: Treatment of acute mania with gabapentin. Am J Psychiatry 1997; 154:287
   Google Scholar
• Ryback RS, Brodsky L, Munasifi F: Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci 1997; 9:301
   Web of Science ®Google Scholar
• McElroy SL, Soutullo CA, Keck PE Jr, Kmetz GF: A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9:99–103
   PubMedGoogle Scholar
• Stanton SP, Keck PE, McElroy SL: Treatment of acute mania with gabapentin. Am J Psychiatry 1997; 154:287
   Google Scholar
• Knoll J, Stegman K, Suppes T: Clinical experience using gaba-pentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998; 49:229–233
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Katzow JJ, Deai SP, Goodwin FK: Gabapentin treatment of mood disorders: a preliminary study. J Clin Psy-chiatry 1998; 59:426–429
   Google Scholar
• Erfuth A, Kammerer C, Grunze H, Normann C, Walden J: An open label study of gabapentin in the treatment of acute mania. J Psychiatry Res 1998; 32:261–264
   Google Scholar
• Frye MA, Ketter TA, Dunn RT, Speer AS, Osuch EA, Cora-Locatelli G, Post RE: Lamotrigine vs. gabapentin monother-apy in unipolar and bipolar illness. Presented at 151rst annual meeting of the American Psychiatric Association, Toronto, May 1998
   Google Scholar
• Walden 3, Hesslinger B, van Calker D, Berger M: Addition of lamotrigine to valproate may enhance efficacy in the treat-ment of bipolar affective disorder. Pharmacopsychiatry 1996; 29:193–195
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Fatemi SH, Woyshville MJ: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]. Am J Psychiatry 1996; 153:1236
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Rapport DJ, Calabrese JR, Thuras P: Lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry 1997; 58:522–527
   PubMed Web of Science ®Google Scholar
• Kusumaker V. Yatham LN: Lamotrigine treatment of rapid cycling bipolar disorder [letter]. Am .1 Psychiatry 1997; 154: 1171–1172
   Google Scholar
• Fogelson DL, Sternbach H: Lamotrigine treatment of refrac-tory bipolar disorder. J Clin Psychiatry 1997; 58:271–273
   PubMedGoogle Scholar
• Sporn J, Sachs G: The anticonvulsant lamotrigine in the treat-ment-resistant manic-depressive illness. J Clin Psychiatry 1997; 17:185–189
   Google Scholar
• Labbate LA, Rubey RN: Lamotrigine for treatment-refrac-tory bipolar disorder [letter]. Am J Psychiatry 1997; 154:1317
   Google Scholar
• Kusumaker V, Yatham LN: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997; 72: 145–148
   Google Scholar
• Kotler M. Matar MA: Lamotrigine in the treatment of resis-tant bipolar disorder. Clin Neuropharmacol 1998; 21:65–66
   Google Scholar
• Brown GM, Stone GI-I, Rathbone MP: Primidone and rapid cycling affective disorders. Lancet 1993; 342:925
   Google Scholar
• Hayes SG: Barbiturate anticonvulsants in refractory affective disorders. Ann Clin Psychiatry 1993; 5:35–44
   Google Scholar
• American Psychiatric Association: DSM-IV. Washington, DC: APA: 1994
   Google Scholar
• American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151 (Dec Suppl):5–12
   Google Scholar
• Bowden CL: Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1998:734–735
   Google Scholar
• Expert Consensus Guideline Series: Treatment of Bipolar Disorder. J Clin Psychiatry 1996; 57:Suppl 12 A
   Google Scholar
• Engel J: Seizures and Epilepsy (Contemporary Neurology Series). Philidelphia: F. A. Davis; 1989:412
   Google Scholar
• Post RM, Uhde TW, Putnam FW, Ballenger JC, Berrettini WH: Kindling and carbamazepine in affective illness. J Nerv Ment Dis 1982; 120:717–731
   Google Scholar